Both GLP-1 and GLP-1/GIP receptor agonists, which include dulaglutide, exenatide, liraglutide, semaglutide, and tirzepatide, have been linked to rare pancreatitis cases
Semaglutide Most Frequently Asked Questions What are peptides and how do they work
Despite already launching a number of new supplements over the past few weeks, it turns out Performix still has a few more releases up its sleeve
However, real-world data shows conflicting persistence trends, with one study revealing that 63% of patients persist for at least one year, while another shows that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks
The effects are relatively slow and dose-dependent, typically requiring 812 weeks to manifest measurable metabolic shifts